Several studies have shown that RACK1 promotes tumor progression and malignancy in colorectal, esophageal, and squamous cell carcinomas of the mouth and lungs, as well as increases the proliferation, migration, and metastasis of breast cancer and is considered an independent prognostic factor (29). Here, RACK1 is linked to breast cancer.